Learn more about the research conducted by Dr. Ntamabyaliro at the UPC-PV and the health priorities in the Democratic Republic of the Congo.
Dr. Nsengi Ntamabyaliro
UPC-PV,
University of Kinshasa
For us, it encompasses our local staff, decades of on-the-ground experience, strong working relationships with stakeholders of all types, cultural competence and a commitment to the region and its people.
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
Because of our global expertise, responsive approaches and proven solutions, we are two steps ahead, ready to deploy immediately in markets worldwide and able to measure study launch in days rather than weeks.
Reach new markets and access the right patient populations.
Benefit from our unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.
By connecting your research strategy with the overarching policy and local communities, we help facilitate communication and engagement efforts for more successful study execution.
As your study needs or the local situation change, we can adapt our processes and workflow. No matter how large or small the project, we remain agile and exact, because your research demands it.
We also invest in our intellectual capital and are experts at rapid start-up and management of complex clinical research at sites diverse in geographic area and research capacity.
Our work complements that of FHI 360, which is grounded in research and science, reinforced by partnerships and focused on strengthening the capacity of individuals, local organizations and national governments.
Together, we can ensure that countries are prepared to respond to threats to
their population’s health.
October 12, 2022
FHI Clinical Inc. is showcasing sub-Saharan Africa as a clinical trial destination through its 8-week FHI Clinical Africa campaign, culminating in a celebration at World Vaccine Congress Europe of the region’s rich cultural heritage and growing target as a hub for global clinical trials.
November 28 – December 1, 2022
Attending the World Vaccine and Immunotherapy Congress West Coast? Schedule a meeting with an FHI Clinical team member who will be attending.
Equity in research plays a vital role in equity in health and health care, starting with clinical trials and carrying through post-marketing access to new vaccines and treatments. Read this blog post for a deeper dive into where the industry stands with equitable access and how it contributes to the success of a trial.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA